Cargando…
Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial
RATIONALE: Idiopathic pulmonary fibrosis (IPF) has a dismal prognosis. Mesenchymal stromal cells (MSCs) have shown benefit in other inflammatory diseases. OBJECTIVES: To evaluate the safety and feasibility of endobronchial administration of bone marrow autologous MSCs (BM-MSC) in patients with mild-...
Autores principales: | Campo, Arantza, González-Ruiz, José María, Andreu, Enrique, Alcaide, Ana B., Ocón, María M., De-Torres, Juan, Pueyo, Jesús, Cordovilla, Rosa, Villaron, Eva, Sanchez-Guijo, Fermín, Barrueco, Miguel, Nuñez-Córdoba, Jorge, Prósper, Felipe, Zulueta, Javier J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236617/ https://www.ncbi.nlm.nih.gov/pubmed/34195252 http://dx.doi.org/10.1183/23120541.00773-2020 |
Ejemplares similares
-
Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
por: Lamo-Espinosa, José María, et al.
Publicado: (2021) -
Autologous mesenchymal stromal cells embedded with Tissucol Duo(®) for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
por: Jiménez, Marcelo F., et al.
Publicado: (2023) -
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II)
por: Lamo-Espinosa, José María, et al.
Publicado: (2018) -
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II)
por: Lamo-Espinosa, José M., et al.
Publicado: (2016) -
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
por: Fernández-Santos, Maria Eugenia, et al.
Publicado: (2022)